Allen Chaves - 16 Sep 2024 Form 4 Insider Report for Klaviyo, Inc. (KVYO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Sep 2024, 17:41:24 UTC
Prior SEC filing
16 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Landon Edmond, Attorney-in-Fact

Key filing fact

Allen Chaves filed Form 4 for Klaviyo, Inc. (KVYO) on 18 Sep 2024.

Key facts

  • This page summarizes Allen Chaves's Form 4 filing for Klaviyo, Inc. (KVYO).
  • 8 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 18 Sep 2024, 17:41.

Change

  • Previous filing in this sequence was filed on 16 Aug 2024.
  • Current net transaction value: -$4,140,174.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KVYO transaction

Series A Common Stock

Conversion of derivative security

Transaction value
$0
Shares
+130,000
Change %
Price
$0.000000
Shares after
130,000
Date
16 Sep 2024
Ownership
Direct
Footnotes
F1
KVYO transaction

Series A Common Stock

Sale

Transaction value
$3,237,144
Shares
-101,066
Change %
-78%
Price
$32.03
Shares after
28,934
Date
16 Sep 2024
Ownership
Direct
Footnotes
F1, F2
KVYO transaction

Series A Common Stock

Sale

Transaction value
$903,030
Shares
-28,934
Change %
-100%
Price
$31.21
Shares after
0
Date
16 Sep 2024
Ownership
Direct
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KVYO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-130,000
Change %
-11%
Price
$0.000000
Shares after
1,028,693
Date
16 Sep 2024
Ownership
Direct
Underlying class
Series B Common Stock
Underlying amount
130,000
Exercise price
$3.06
Footnotes
F1, F4
KVYO transaction Derivative

Series B Common Stock

Options Exercise

Transaction value
$0
Shares
+130,000
Change %
+57%
Price
$0.000000
Shares after
356,314
Date
16 Sep 2024
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
130,000
Exercise price
Footnotes
F1, F5
KVYO transaction Derivative

Series B Common Stock

Conversion of derivative security

Transaction value
$0
Shares
-130,000
Change %
-36%
Price
$0.000000
Shares after
226,314
Date
16 Sep 2024
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
130,000
Exercise price
Footnotes
F1, F5
KVYO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-32,733
Change %
-3.2%
Price
$0.000000
Shares after
995,960
Date
17 Sep 2024
Ownership
Direct
Underlying class
Series B Common Stock
Underlying amount
32,733
Exercise price
$3.06
Footnotes
F4
KVYO transaction Derivative

Series B Common Stock

Options Exercise

Transaction value
$0
Shares
+32,733
Change %
+14%
Price
$0.000000
Shares after
259,047
Date
17 Sep 2024
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
32,733
Exercise price
Footnotes
F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.50 to $32.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.65 to $31.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The shares underlying this option are fully vested and exercisable by the Reporting Person as of the date hereof.

Footnote F5

Each share of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), of the Issuer, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.

Footnote F6

Consists of (i) 178,203 shares of Series B Common Stock and (ii) 80,844 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .